(KALA) Kala Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Kala Pharmaceuticals | (KALA) share price targets
Complete technical analysis of Kala Pharmaceuticals (KALA) by charts plus indicators, forecast predictions and share price targets for Kala Pharmaceuticals (KALA)
Kala Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-10-17 View latest technical analysis
10 day averaged volume of Kala Pharmaceuticals is 9200
Date | Daily Closing Price | Open | High | Low | Volume |
17 Thu Oct 2024 | 5.11 | 5.25 | 5.30 | 4.95 | 1.359 times |
16 Wed Oct 2024 | 5.26 | 5.12 | 5.39 | 5.12 | 1.087 times |
15 Tue Oct 2024 | 5.20 | 5.17 | 5.25 | 5.04 | 0.685 times |
14 Mon Oct 2024 | 5.17 | 5.19 | 5.39 | 5.15 | 0.957 times |
11 Fri Oct 2024 | 5.27 | 5.26 | 5.37 | 5.19 | 0.663 times |
10 Thu Oct 2024 | 5.26 | 5.35 | 5.35 | 5.13 | 0.913 times |
09 Wed Oct 2024 | 5.23 | 5.30 | 5.39 | 5.08 | 2.565 times |
08 Tue Oct 2024 | 5.31 | 5.35 | 5.37 | 5.30 | 0.728 times |
07 Mon Oct 2024 | 5.35 | 5.31 | 5.40 | 5.25 | 0.826 times |
04 Fri Oct 2024 | 5.40 | 5.28 | 5.40 | 5.25 | 1 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 5.2, but if it comes above 5.2, then a intra day buy could be more profitable.
If you take a sell trade below 5.2, then use 5.2 as stoploss and 5 as target. However if you take a buy trade in stock , then use 5.2 as stoploss and 5.37 as target.
Share price targets for Kala Pharmaceuticals (KALA)
Target Type | Value |
Downside Target | 4.21 |
Downside Target | 4.95 |
Downside Target | 5.08 |
Upside Target | 5.25 |
Upside Target | 5.39 |
Upside Target | 5.70 |
Upside Target | 5.91 |
Upside Target | 6.09 |
Upside Target | 6.20 |
Upside Target | 6.32 |
Upside Target | 6.45 |
Upside Target | 7.60 |
Upside Target | 7.88 |
Intraday share price targets for Kala Pharmaceuticals (KALA)
Target Type | Value |
Downside Intraday Target | 4.91 |
Downside Intraday Target | 4.71 |
Upside Intraday Target | 5.35 |
Upside Intraday Target | 5.59 |
Upside Intraday Target | 5.15 |
Weekly technical analysis of Kala Pharmaceuticals (KALA)
Date | Weekly Closing Price | Open | High | Low | Volume |
17 Thu Oct 2024 | 5.11 | 5.19 | 5.39 | 4.95 | 0.718 times |
11 Fri Oct 2024 | 5.27 | 5.31 | 5.40 | 5.08 | 1.354 times |
04 Fri Oct 2024 | 5.40 | 5.40 | 5.76 | 5.25 | 0.497 times |
27 Fri Sep 2024 | 5.35 | 5.91 | 5.91 | 5.12 | 0.821 times |
20 Fri Sep 2024 | 5.79 | 5.93 | 6.09 | 5.73 | 2.397 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Kala Pharmaceuticals (KALA)
Date | Monthly Closing Price | Open | High | Low | Volume |
17 Thu Oct 2024 | 5.11 | 5.70 | 5.70 | 4.95 | 0.478 times |
30 Mon Sep 2024 | 5.70 | 5.85 | 6.20 | 5.12 | 0.769 times |
30 Fri Aug 2024 | 5.85 | 6.41 | 6.45 | 5.46 | 0.232 times |
31 Wed Jul 2024 | 6.50 | 7.05 | 7.88 | 6.32 | 0.109 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Kala Pharmaceuticals (KALA)
Price action analysis of Kala Pharmaceuticals ( (KALA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Kala Pharmaceuticals ( (KALA) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Kala Pharmaceuticals ( (KALA) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Kala Pharmaceuticals ( (KALA) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Kala Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Kala Pharmaceuticals in short term and the sell signal is strong.
Kala Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Kala Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Kala Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 5.25 and Kala Pharmaceuticals (KALA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Kala Pharmaceuticals (KALA) stock. Volume based technical analysis of Kala Pharmaceuticals (KALA) stock is negative.
Kala Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Kala Pharmaceuticals ( (KALA) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Kala Pharmaceuticals ( (KALA) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Kala Pharmaceuticals ( (KALA) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Kala Pharmaceuticals ( (KALA) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Kala Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Kala Pharmaceuticals in short term and the sell signal is strong.
Kala Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Kala Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Kala Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 5.25 and Kala Pharmaceuticals (KALA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Kala Pharmaceuticals (KALA) stock. Volume based technical analysis of Kala Pharmaceuticals (KALA) stock is negative.
Kala Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.